• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合素靶向超顺磁性氧化铁致肝损伤大鼠肝星状细胞激活的磁共振成像

MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide.

机构信息

Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Eur Radiol. 2011 May;21(5):1016-25. doi: 10.1007/s00330-010-1988-z. Epub 2010 Oct 25.

DOI:10.1007/s00330-010-1988-z
PMID:20972894
Abstract

OBJECTIVE

To demonstrate the feasibility of the ultrasmall superparamagnetic iron oxide (USPIO) modified by cyclo (Arg-Gly-Asp-Try-Cys) peptide (c(RGDyC)-USPIO) for targeting hepatic stellate cells (HSCs).

MATERIALS AND METHODS

A c(RGDyC)-USPIO probe was prepared by conjugating c(RGDyC) with USPIO through a thiol-maleinide interaction. The specificity of c(RGDyC)-USPIO for HSCs was investigated in vitro. In vivo, normal and fibrosis rats were treated with either c(RGDyC)-USPIO or USPIO, and magnetic resonance imaging (MRI) of the rats performed after administration of the probes for 4 h. The T2 relaxation times changes before and after probe injection were analyzed and the locations of probes in normal or injured mice were identified histologically.

RESULTS

The hydrodynamic size of c(RGDyC)-USPIO was 13 ± 3 nm. HSCs took up more specific probes than plain ones. The reduction of T2 relaxation times in fibrosis rat by c(RGDyC)-USPIO was much greater than that by USPIO (P < 0.05). Prussian blue staining and transmission electron microscopy of the injured rat liver treated with c(RGDyC) demonstrated that c(RGDyC)-USPIO were specifically engulfed by the activated HSCs.

CONCLUSION

In vivo cellular targeted imaging of activated HSCs in liver fibrosis using c(RGDyC)-USPIO targeting α(v)β(3) integrins was feasible using a clinical 1.5-Tesla MR system.

摘要

目的

展示经环(精氨酸-甘氨酸-天冬氨酸-半胱氨酸)肽(c(RGDyC)-超顺磁性氧化铁(USPIO))修饰的超小超顺磁性氧化铁(USPIO)用于靶向肝星状细胞(HSCs)的可行性。

材料与方法

通过巯基-马来酰亚胺相互作用将 c(RGDyC)与 USPIO 缀合,制备 c(RGDyC)-USPIO 探针。在体外研究 c(RGDyC)-USPIO 对 HSCs 的特异性。在体内,正常和纤维化大鼠分别用 c(RGDyC)-USPIO 或 USPIO 处理,并在给予探针后 4 小时对大鼠进行磁共振成像(MRI)。分析探针注射前后 T2 弛豫时间的变化,并通过组织学鉴定探针在正常或受损小鼠中的位置。

结果

c(RGDyC)-USPIO 的水动力粒径为 13±3nm。HSCs 摄取的特异性探针多于普通探针。c(RGDyC)-USPIO 使纤维化大鼠 T2 弛豫时间的减少明显大于 USPIO(P<0.05)。用 c(RGDyC)处理受损大鼠的肝脏普鲁士蓝染色和透射电镜显示,c(RGDyC)-USPIO 被活化的 HSCs 特异性吞噬。

结论

使用靶向α(v)β(3)整合素的 c(RGDyC)-USPIO 对肝纤维化中活化的 HSCs 进行体内细胞靶向成像,在临床 1.5T MR 系统中是可行的。

相似文献

1
MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide.整合素靶向超顺磁性氧化铁致肝损伤大鼠肝星状细胞激活的磁共振成像
Eur Radiol. 2011 May;21(5):1016-25. doi: 10.1007/s00330-010-1988-z. Epub 2010 Oct 25.
2
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.利用靶向整合素αvβ₃的超小超顺磁性氧化铁对大鼠模型肝纤维化进行分期时,对活化肝星状细胞的分子磁共振成像
Int J Nanomedicine. 2016 Mar 18;11:1097-108. doi: 10.2147/IJN.S101366. eCollection 2016.
3
Development and study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma.用于肝细胞癌的双特异性磁共振成像分子探针的研制与研究。
World J Gastroenterol. 2019 Jun 28;25(24):3030-3043. doi: 10.3748/wjg.v25.i24.3030.
4
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.使用临床1.5-T磁共振扫描仪,通过RGD共轭超小超顺磁性氧化铁颗粒对肿瘤血管生成进行特异性靶向。
Cancer Res. 2007 Feb 15;67(4):1555-62. doi: 10.1158/0008-5472.CAN-06-1668.
5
Integrin αβ-targeted MR molecular imaging of breast cancer in a xenograft mouse model.整合素 αβ 靶向磁共振分子成像在异种移植小鼠乳腺癌模型中的应用。
Cancer Imaging. 2021 Jun 29;21(1):44. doi: 10.1186/s40644-021-00411-9.
6
Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.二氧化硅和烷氧基硅烷包覆的超小超顺磁性氧化铁颗粒:一种用于磁共振成像标记细胞的有前景的工具。
Langmuir. 2007 Jan 30;23(3):1427-34. doi: 10.1021/la061879k.
7
Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.使用 4.7T 磁共振扫描仪,通过 RGD 偶联超顺磁氧化铁纳米颗粒特异性靶向肺癌中的血管生成。
Chin Med J (Engl). 2013 Jun;126(12):2242-7.
8
Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging.新型靶向整合素αvβ3 高表达肿瘤细胞的磁共振成像肽。
J Magn Reson Imaging. 2011 Aug;34(2):395-402. doi: 10.1002/jmri.22620.
9
Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor.磁共振成像造影剂:cRGD-氧化铁纳米颗粒及其在肿瘤诊断中的作用。
J Nanosci Nanotechnol. 2011 May;11(5):3800-7. doi: 10.1166/jnn.2011.3861.
10
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.使用带有RGD共轭超小超顺磁性氧化铁纳米颗粒的MRI对人鼻咽癌异种移植模型中早期抗血管生成治疗反应进行无创监测。
Int J Nanomedicine. 2016 Nov 14;11:5671-5682. doi: 10.2147/IJN.S115357. eCollection 2016.

引用本文的文献

1
Fibrotic Disease: from Signaling Pathways and Biomarkers to Molecular Imaging.纤维化疾病:从信号通路、生物标志物到分子成像
Mol Imaging Biol. 2025 Aug 11. doi: 10.1007/s11307-025-02038-9.
2
A FAPα-activated MRI nanoprobe for precise grading diagnosis of clinical liver fibrosis.一种 FAPα 激活的 MRI 纳米探针,用于临床肝纤维化的精确分级诊断。
Nat Commun. 2024 Sep 13;15(1):8036. doi: 10.1038/s41467-024-52308-3.
3
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis.用于肝纤维化诊断的非侵入性分子成像探针的进展

本文引用的文献

1
18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.18F 标记的半乳糖和 PEG 化 RGD 二聚体用于 PET 成像αvβ3 整合素表达。
Mol Imaging Biol. 2010 Oct;12(5):530-8. doi: 10.1007/s11307-009-0284-2. Epub 2009 Dec 1.
2
Parametric exploration of the liver by magnetic resonance methods.磁共振方法对肝脏的参数探索。
Eur Radiol. 2009 Nov;19(11):2594-607. doi: 10.1007/s00330-009-1470-y. Epub 2009 Jun 6.
3
Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.
Biomater Res. 2024 Jul 1;28:0042. doi: 10.34133/bmr.0042. eCollection 2024.
4
Emerging MRI techniques for molecular and functional phenotyping of the diseased heart.用于患病心脏分子和功能表型分析的新兴磁共振成像技术。
Front Cardiovasc Med. 2022 Dec 5;9:1072828. doi: 10.3389/fcvm.2022.1072828. eCollection 2022.
5
Enhanced US/CT/MR imaging of integrin αβ for liver fibrosis staging in rat.整合素αβ在大鼠肝纤维化分期中的增强超声/CT/磁共振成像
Front Chem. 2022 Oct 3;10:996116. doi: 10.3389/fchem.2022.996116. eCollection 2022.
6
Size, shape, charge and "stealthy" surface: Carrier properties affect the drug circulation time .大小、形状、电荷及“隐身”表面:载体特性影响药物循环时间。
Asian J Pharm Sci. 2021 Jul;16(4):444-458. doi: 10.1016/j.ajps.2020.07.005. Epub 2020 Aug 29.
7
Quantitative evaluation of hepatic integrin αβ expression by positron emission tomography imaging using F-FPP-RGD in rats with non-alcoholic steatohepatitis.使用F-FPP-RGD的正电子发射断层扫描成像对非酒精性脂肪性肝炎大鼠肝脏整合素αβ表达进行定量评估。
EJNMMI Res. 2020 Oct 7;10(1):118. doi: 10.1186/s13550-020-00704-3.
8
Advances in functional and molecular MRI technologies in chronic liver diseases.慢性肝脏疾病的功能和分子 MRI 技术进展。
J Hepatol. 2020 Nov;73(5):1241-1254. doi: 10.1016/j.jhep.2020.06.020. Epub 2020 Jun 22.
9
Molecular Probes for Imaging Fibrosis and Fibrogenesis.用于纤维化和纤维发生成像的分子探针。
Chemistry. 2019 Jan 24;25(5):1128-1141. doi: 10.1002/chem.201801578. Epub 2018 Nov 21.
10
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.利用靶向整合素αvβ₃的超小超顺磁性氧化铁对大鼠模型肝纤维化进行分期时,对活化肝星状细胞的分子磁共振成像
Int J Nanomedicine. 2016 Mar 18;11:1097-108. doi: 10.2147/IJN.S101366. eCollection 2016.
原钒酸盐对大鼠肝星状细胞活化及肝纤维化的抑制作用
Am J Pathol. 2009 Mar;174(3):881-90. doi: 10.2353/ajpath.2009.080261. Epub 2009 Jan 22.
4
Advances in antifibrotic therapy.抗纤维化治疗的进展。
Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):803-16. doi: 10.1586/17474124.2.6.803.
5
Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function.瘦素信号通路的竞争性抑制通过调节星状细胞功能改善肝纤维化。
Hepatology. 2009 Jan;49(1):278-86. doi: 10.1002/hep.22584.
6
Coagulation and fibrosis in chronic liver disease.慢性肝病中的凝血与纤维化
Gut. 2008 Dec;57(12):1722-7. doi: 10.1136/gut.2008.150748.
7
Stellate cell contraction: role, regulation, and potential therapeutic target.星状细胞收缩:作用、调节及潜在治疗靶点
Clin Liver Dis. 2008 Nov;12(4):791-803, viii. doi: 10.1016/j.cld.2008.07.004.
8
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.在MDA-MB-435异种移植小鼠模型中,使用靶向α5β1(ανβ3)的治疗诊断纳米颗粒进行血管生成的三维磁共振成像。
FASEB J. 2008 Dec;22(12):4179-89. doi: 10.1096/fj.08-112060. Epub 2008 Aug 12.
9
Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair.确定肝纤维化的治疗靶点:利用炎症与修复生物学特性
Pharmacol Res. 2008 Aug;58(2):129-36. doi: 10.1016/j.phrs.2008.06.011. Epub 2008 Jul 4.
10
Liver fibrosis.肝纤维化
Biochem J. 2008 Apr 1;411(1):1-18. doi: 10.1042/BJ20071570.